CO2 laser vaporization for the treatment of vaginal intraepithelial neoplasia: effectiveness and predictive factors for recurrence

Objective: To evaluate the outcome of vaginal intraepithelial neoplasia (VaIN) treatment with CO2 laser vaporization in terms of local recurrence and progression to vaginal carcinoma. Additionally, the authors investigated the predictive factors for first recurrence. Materials and Methods: The medical records of all patients treated for VaIN with CO2 laser vaporization at Sant’Anna Hospital in Turin (1995-2012), were retrospectively reviewed. A univariate logistic model was applied to evaluate selected clinical features as predictive factors for recurrence. A multivariate logistic regression analysis was then carried out including significant risk factors after univariate analysis (p < 0.05). Results: The analysis included 285 out of 302 patients. Seventy-one (25%) women relapsed; of these 24 VaIN 1 (22%), 37 VaIN 2 (27%), and ten VaIN 3 (26%). The median time to the first recurrence was 5.2 months (1.4?127.8) for VaIN 1, 6.6 months (1?85.2) for VaIN 2, and 3.6 months (1.2?62) for VaIN 3. Sixty-one out of 71 patients were retreated with CO2 laser vaporization. At the last follow-up visit, 273 (96%) women were free from VaIN. No patients progressed to vaginal carcinoma. The multivariate model showed a higher risk of VaIN recurrence in the case of previous hysterectomy (HR 3.3, 95% CI 1.7?6.3, p < 0.001) and concomitant H-SIL on the Pap smear (HR 1.9, 95% CI 1.2?3.1, p = 0.008). Conclusion: CO2 laser vaporization is an effective low impact treatment for VaIN. Despite this, VaIN recur, in particular in cases of previous hysterectomy and concomitant H-SIL on the Pap smear. An intensive follow-up is proposed for women with a high risk of VaIN relapse.

CO2 laser vaporization; Predictive factors; Relapses; Vaginal intraepithelial neoplasia.

[1] Gunderson C., Nugent E., Elfrink S., Gold M., Moore K.: “A contem-porary analysis of epidemiology and management of vaginal intraep-ithelial neoplasia”. Am. J. Obstet. Gynecol., 2013, 208, 410 e1.

[2] Atay V., Muhcu M., Caliskan C.: “Treatment of vaginal intraepithelial neoplasia”. Cancer Therapy, 2007, 5, 19.

[3] Murta E.F.C., Junior M.A.N., Sempionato L.R.F., Costa M., Maluf P.J.: “Vaginal intraepithelial neoplasia: clinical-therapeutic analysis of 33 cases”. Arch. Gynecol. Obstet., 2005, 272, 261.

[4] Boonlikit S., Noinual N.: “Vaginal intraepithelial neoplasia: a retro-spective analysis of clinical features and colpohistology”. J. Obstet. Gynaecol. Res., 2010, 1, 94.

[5] Dodge A., Eltabbakh H., Mount L., Walket P., Morgan A.: “Clinical features and risk of recurrence among patients with vaginal intraep-ithelial neoplasia”. Gynecol. Oncol., 2001, 83, 363.

[6] Menguellet S.A., Collinet P., Debarge V.H., Nayama M., Vinatier D., Leroy J.L.: “Management of multicentric lesions of the lower genital tract”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2007, 132, 116.

[7] Chao A., Chen T.S., Hsueh C., Huang C.C., Yang J.E., et al.: “Human papillomavirus in vaginal intraepithelial neoplasia”. Int. J. Cancer, 2012, 131, E259.

[8] Stokes-Lampard H., Wilson S., Waddell C., Ryan A., Holder R., Kehoe S.: “Vaginal vault smears after hysterectomy for reasons other than malignancy: a systematic review of the literature”. BJOG, 2006, 113, 1354.

[9] Li H., Guo Y., Zhang J., Qiao J., Geng L.: “Risk factors for the devel-opment of vaginal intraepithelial neoplasia”. Chin. Med. J., 2012, 125, 1219.

[10] Schockaert S., Poppe W., Arbyn M., Vergutus T., Vergutus J.: “Incidence of vaginal intraepithelial neoplasia after isterectomy for cervical intraepithelial neoplasia: a retrospective study”. Am. J. Obstet. Gynecol., 2008, 199, 113.e1

[11] Liao J., Jean S., Wilkinson-Ryan I., Ford A.E., Tanyi J.L., Hagemann A.R., et al.: “Vaginal intraepithelial neoplasia (VaIN) after radiation therapy for gynecologic malignancies: a clinically recalcitrant entity”. Gynecol. Oncol., 2011, 120, 108.

[12] Likes W., Santoso J.T., Wan J.: “A cross-sectional analysis of lower genital tract intraepithelial neoplasia in immune-compromised women with abnormal pap”. Arch. Gynecol. Obstet., 2013, 287, 743.

[13] Sherman J.F., Mount S.H., Evans M.F., Skelly J., Simmons-Arnold L.,Eltabbakh G.H.: “Smoking increases the risk of high-grade vaginal intraepithelial neoplasia in women with oncogenic human papillomavirus”. Gynecol. Oncol., 2008, 110, 396.

[14] Rome R.M., Engalnd P.G.: “Management of vaginal intraepithelial neoplasia: a series of 132 cases with long term follow-up”. Int. J. Gynecol.Cancer, 2002, 132, 116.

[15] Sillman F.H., Frutcher R.G., Chen Y.S., Camilien L., Sedlis A., Mc- Tigue E.: “Vaginal intraepithelial neoplasia: risk factors for persistence, recurrence and invasion and its management”. Am. J. Obstet. Gynecol., 1997, 176, 93.

[16] Campagnutta E., Parin A., De Piero G., Giorda G., Gallo A., ScarabelliC.: “Treatment of vaginal intraepithelial neoplasia (VaIN) with the carbon dioxide laser”. Clin Exp Obstet Gynecol., 1999, 26, 127.

[17] Costa S., Pesaresi M., Terzano P., Falasca A., Arrighi V.: “Terapia della neoplasia intraepiteliale vaginale”. In: Costa S. (ed). Patologia della vagina. Modena: Athena, 2011, 2, 717.

[18] Perrotta M., Marchitelli C.E., Velazco A., Tauscher P., Lopez G., Peremateu M.S.: “Use of CO2 laser vaporization for the treatment of highgrade vaginal intraepithelial neoplasia”. J. Low. Genit. Tract Dis., 2013, 17, 23.

[19] Hoffman M.S., Roberts W.S., LaPolla J.P., Fiorica J.V., Cavanagh D.: “Laser vaporization of grade 3 vaginal intraepithelial neoplasia”. Am. J. Obstet. Gynecol., 1991, 165, 1342.

[20] Benedet J.L., Wilson P.S., Matisic J.P.: “Epidermal thickness measurements in vaginal intraepithelial neoplasia. A basis for optimal CO2 laser vaporization”. J. Reprod. Med., 1992, 37, 809.

[21] Gurumurthy M., Cruickshank M.E.: “Management of vaginal intraepithelial neoplasia”. J. Low. Genit. Tract Dis., 2012, 16, 306.

[22] Yalcin O.T., Rutherford T.J., Chambers S.K., Chambers J.T., Schwarts P.E.: “Vaginal intraepithelial neoplasia: treatment by carbon dioxide laser and risk factors for failure”. Eur. J. Obstet. Gynecol. Reprod. Biol., 2003, 106, 64.

[23] Massad L.S.:”Outcomes after diagnosis of vaginal intraepithelial neoplasia”. J. Low. Genit. Tract Dis., 2008, 12, 16.

[24] Volante R., Pasero L., Saraceno L., Magurano M., Ribaldone R.: “Carbon dioxide laser surgery in colposcopy for cervicovaginal intraepithelial neoplasia treatment. 10 years experience and failure analysis”. Eur. J. Obstet. Gynecol., 1992, 13, 78.

[25] Zeligs K.P., Byrd K., Tarney C.M., Howard R.S., Sims B.D., Hamilton C.A., Stany M.P.: “A Clinicopathologic study of vaginal intraepithelial neoplasia”. Obstet. Gynecol., 2013, 122, 1223.

[26] Di Donato V., Bellati F., Fischetti M., Plotti F., Perniola G., Benedetti Panici P.: “Vaginal cancer”. Crit. Rev. Oncol Hematol., 2012, 81, 286.

[27] Kim H.S., Park N.H., Park I.A., Park J.H., Chung H.H., Kim J.W., et al.: “Risk factors for recurrence of vaginal intraepithelial neoplasia in the vaginal vault after laser vaporization”. Lasers Surg. Med., 2009, 41, 196.

[28] De Vusyst H., Clifford G., Nascimento M., Madeleine M., Franceschi S.: “Prevalence and type distribution of human papillomavirus and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis”. Int. J. Cancer, 2009, 124, 1626.

[29] Wee W.W., Chia Y.N., Yam P.K.L.: “Diagnosis and treatment of vaginal intraepithelial neoplasia”. Int. J. Gynaecol. Obstet., 2012, 117, 15.

[30] Sherman A.L.: “Laser therapy for vaginal intraepithelial neoplasia after hysterectomy”. J. Reprod. Med., 1990, 35, 941.